Company or ticker...

NeoGenomics

NeoGenomics provides cancer-focused genetic testing and oncology diagnostic services.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

NEO

2.1B

2.7

n/a

39.48%

Key Facts

M. Cap

PS

PE

YTD

2.1B

2.7

n/a

39.48%

10MA

20MA

50MA

200MA

$NEO